Contact Us 

contactus@carepathrxllc.com
News

Delivering Fast and Easy Access to More Generic Oncology Medications

BioPlus Specialty Pharmacy has expanded its “Hope Delivered in 24 Hours” Program.

ALTAMONTE SPRINGS, Fl., July 13, 2022 – BioPlus Specialty Pharmacy, a CarepathRx company, today announced the expansion of its “Hope Delivered in 24 Hours” program. The program ensures that all formulary, generic oncology medications are ready to ship to patients within 24 hours of receiving a complete physician referral.

BioPlus is the only specialty pharmacy to have generic oncology medications ready to ship to patients in just one day. The program launched earlier this year with single day processing for the medication capecitabine. Now expansion guarantees a quick turnaround for all of the most commonly prescribed generic oncology medications, including abiraterone, bexarotene, capecitabine, deferasirox, erlotinib, everolimus, imatinib, nilutamide, sunitinib, temozolomide, and other oncology generics.

BioPlus was the first specialty pharmacy to shorten the excessive wait times oncology patients often experience between diagnosis and starting therapy. Through the company’s capecitabine program, prescribing office staff could make their jobs easier, reduce the stress associated with patient therapy access delays, and enhance their overall patient experiences. After achieving these positive outcomes, BioPlus expanded this delivery guarantee across all generic oncology medications.

“Office staff experience a lot of stress with trying to get patients their medications as quickly as possible,” explained Angie Houck, Senior Vice President of Sales Operations at BioPlus. “We want to help eliminate this stress so they can focus on patient care. We continue to optimize our processes so we can deliver hope and life-saving medications in record time.”

All BioPlus oncology patients embark on their medication journeys with the company’s Power of 2 promise. It all starts with the BioPlus 2 Hour Patient Acceptance Guarantee™, where physicians’ offices are notified in less than two hours whether a referred patient is accepted for treatment or not.

“Timely treatment means better outcomes. Better outcomes result in less-stressed office staff and patients,” added Mark Montgomery, CEO and President of BioPlus. “That’s why we’re committed to being faster than other specialty pharmacies. It’s the heart of our Power of 2 promise and our commitment to delivering hope in 24 hours.”

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves dozens of health systems and over 600 hospitals, with more than 2,000 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

About BioPlus Specialty Pharmacy
Meet the first and only independent, national specialty pharmacy to back up “fast and easy” with the Power of 2: BioPlus Specialty Pharmacy. Physician offices know in less than two hours whether a referred patient is accepted for treatment with the company’s 2-Hour Patient Acceptance Guarantee™. Prescriptions then move fast through the 2 Day Ready 2 Ship™ process. For qualifying prescriptions, medication refills are an easy 2 clicks away. Learn more at www.BioPlusRx.com.

Leave a Reply

Your email address will not be published.